Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished
-Lipella Granted Two Orphan Drug Designations by FDA- Pittsburgh, PA, December 20, 2023 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella," "our," "us" or the "Company") a pioneering, clinical-stage pharmaceutical company, celebrates its first anniversary as a...
SinglePoint Announces Closing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split
Phoenix, AZ, December 19, 2023 - SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a diversified holding company principally engaged through its subsidiaries in providing renewable energy solutions and energy-efficient applications to drive better...
NRx Pharmaceuticals Secures IND for Urinary Tract Infection Treatment
New York, December 19, 2023 - NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has been granted FDA clearance for its Investigational New Drug Application (IND) for NRX-101 for the treatment of complicated Urinary Tract infections (cUTI). The company’s...
PPJ Healthcare Enterprises, Inc. signed new Billing Accounts
TAMPA, FLORIDA, December 19, 2023 - PPJ Healthcare Enterprises Inc. (OTC Pink: PPJE) has announced today that it closed one billing agreement with a ‘pain management physicians’ group to provide their billing and collections. “We have been successful in providing...
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
POMPANO BEACH, FLORIDA, December 19, 2023 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces it has...
PRISM Analysis: Why Did Battalion Oil Shares Soar on Friday?
NEW YORK, NY, December 18, 2023 - Shares in Battalion Oil Corporation (NYSE American: BATL) surged more than 80% on Friday after the company announced it has agreed to be acquired by Fury Resources, Inc. for $9.80 per share in cash, which represents a total...
MindMed Advances Treatment for Generalized Anxiety Disorder
NEW YORK, NY, December 18, 2023 - Biopharmaceutical company, Mind Medicine (Nasdaq: MNMD) has announced positive results from its Phase 2b clinical trial of MM-120 (lysergide d-tartrate) in generalized anxiety disorder (GAD). The trial met its primary endpoint, with...
SinglePoint Rings the Opening Bell at Cboe Global Markets Exchange
Phoenix, AZ, December 18, 2023 - SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a renewable solar energy and sustainable solutions provider participated in the iconic opening bell ringing ceremony, Friday December 15th, 2023. The event marked the...
PRISM AdTech & Media Company Spotlight: Creative Realities Illuminates the Future of Experiential Design
In the fast-paced landscape of experiential design and technology, Creative Realities Inc. seamlessly integrates the physical and digital realms in creating immersive experiences that captivate audiences across various industries. NEW YORK, NY, December 16, 2023 -...
Rogue One Provides Corporate Update
WASHINGTON, DC, December 15, 2023 -As many are aware, Rogue One, Inc. ("Company") has not submitted any financial statements subsequent to the Quarterly Report dated September 30, 2021. It is imperative to note that the recent action undertaken by the Securities and...